Xencor Inc. Stock
Price
Target price
€9.85
€9.85
0.000%
-
0.000%
€22.44
20.02.26 / Stuttgart Stock Exchange
WKN: A1W96L / Symbol: XNCR / Name: Xencor / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Xencor Inc. Stock
The Xencor Inc. price is unchanged compared to yesterday.
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 22 € there is potential for a 123.35% increase which would mean more than doubling the current price of 9.85 € for Xencor Inc..
Pros and Cons of Xencor Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xencor Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | 0.000% | 3.141% | -7.944% | -32.993% | -22.441% | -69.599% | -76.659% |
| Iovance Biotherapeutics Inc. | 1.220% | 12.889% | 17.326% | -54.209% | 3.204% | -64.989% | -93.712% |
| United Therapeutics | -0.270% | 1.895% | 2.329% | 16.876% | -4.376% | 70.962% | 181.793% |
| Neurocrine Bioscience | -1.900% | 4.400% | -4.922% | -1.266% | -10.569% | 12.933% | 16.688% |
Comments
Xencor (NASDAQ:XNCR) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its price target raised by analysts at Royal Bank Of Canada from $18.00 to $19.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat